Similar articles

• Comment on: pharmacokinetics of inhaled colistin in patients with cystic fibrosis.

  Li J, Nation RL. Li J, et al. J Antimicrob Chemother. 2006 Jul;58(1):222-3; author reply 223. doi: 10.1093/jac/dkl169. Epub 2006 Apr 26. J Antimicrob Chemother. 2006. PMID: 16641116 No abstract available.
• Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis.

  Adeboyeku D, Scott S, Hodson ME. Adeboyeku D, et al. J Cyst Fibros. 2006 Dec;5(4):261-3. doi: 10.1016/j.jcf.2006.05.009. Epub 2006 Jun 27. J Cyst Fibros. 2006. PMID: 16807142 Clinical Trial.
• In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.

  Güzel CB, Gerçeker AA. Güzel CB, et al. Chemotherapy. 2008;54(2):147-51. doi: 10.1159/000119741. Epub 2008 Mar 6. Chemotherapy. 2008. PMID: 18322363
• Use of colistin in children.

  Tamma PD, Lee CK. Tamma PD, et al. Pediatr Infect Dis J. 2009 Jun;28(6):534-5. doi: 10.1097/INF.0b013e3181ac4980. Pediatr Infect Dis J. 2009. PMID: 19483519 Review. No abstract available.
• Unusual distribution, pharmacokinetics, and metabolism of some drugs and their implications to pharmacotherapy.

  Prandota J. Prandota J. Am J Ther. 2000 Sep;7(5):332-40. doi: 10.1097/00045391-200007050-00014. Am J Ther. 2000. PMID: 11317183 Review. No abstract available.